Laser Resurfacing Versus Dermabrasion for Scar Revision

University of Minnesota6 enrolled

Overview

Dermabrasion has been the historical standard used for resurfacing scars on the skin. Recently, fractionated laser therapy has been FDA approved for scar resurfacing. This study intends to compare dermabrasion versus fractionated laser therapy for scar resurfacing.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Cicatrix Dermabrasion Coagulation, Laser

Interventions

Fractionated laserDEVICE

Fractionated laser in the form of the Re:Pair CO2 laser manufactured by Solta Medical.

DermabrasionDEVICE

Diamond Fraise Dermabrasion will be performed in standard fashion down to papillary dermis.

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Post-surgical or post traumatic scar on face or scalp. * Age 18 or older * Able to read and comprehend English * Willing to follow treatment schedule and post treatment care requirements * Signed the informed consent form * Fitzpatrick skin type I-III Exclusion Criteria: * known photosensitivity * Taken any medications known to induce photosensitivity in previous three months * Taken Accutane within past 12 months * Pregnant or nursing * Currently on topical or oral antibiotics * Immunocompromised status * Skin type IV or greater

Locations (1)

Zel Skin and Laser

Edina, Minnesota, United States

Outcomes

Primary Outcomes

Safey Data Score Based on Ordinal Ratings of Erythema, Edema, Bleeding, Eschar After Resurfacing

Erythema, edema, bleeding, and eschar after resurfacing were used as indicators of safety. Each was judged based on a 4 point ordinal scale 0=absent, 1=mild, 2=moderate, 3=severe.

Time frame: Day 0, Week1, Month 1

Secondary Outcomes

Visual Analog Scale for Assessing Scar Improvement.

Visual Analog Scale for assessing scar improvement. 0 : Worsening or no improvement 1. : 1-25% improvement 2. : 26-50% improvement 3. : 51-75% improvement 4. : 76-100% improvement

Time frame: 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.